Cargando…

Clinical Outcome of Edoxaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation and Diabetes Mellitus: Results from a Multicenter, Propensity-Matched, Real-World Cohort Study

Diabetes mellitus (DM) is a chronic metabolic disease which is independently associated with unfavorable clinical outcomes in patients with atrial fibrillation (AF). Few real-world data are available about the clinical performance of non-vitamin K oral anticoagulants (NOACs) among patients with atri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russo, Vincenzo, Attena, Emilio, Rago, Anna, Melillo, Enrico, Di Micco, Pierpaolo, Papa, Andrea Antonio, Napolitano, Giovanni, D’Onofrio, Antonio, Golino, Paolo, Nigro, Gerardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356851/ https://www.ncbi.nlm.nih.gov/pubmed/32471222 http://dx.doi.org/10.3390/jcm9061621

Ejemplares similares

Direct Current Cardioversion in Atrial Fibrillation Patients on Edoxaban Therapy Versus Vitamin K Antagonists: a Real-world Propensity Score–Matched Study
por: Rago, Anna, et al.
Publicado: (2020)

Non Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients Scheduled for Electrical Cardioversion: A Real-Life Propensity Score Matched Study
por: Rago, Anna, et al.
Publicado: (2021)

Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study
por: Russo, Vincenzo, et al.
Publicado: (2019)

Gender Differences in Atrial Fibrillation: From the Thromboembolic Risk to the Anticoagulant Treatment Response
por: Rago, Anna, et al.
Publicado: (2023)

Apixaban in a Morbid Obese Patient with Atrial Fibrillation: A Clinical Experience Using the Plasmatic Drug Evaluation
por: Russo, Vincenzo, et al.
Publicado: (2020)

Single-Chamber Leadless Cardiac Pacemaker in Patients Without Atrial Fibrillation: Findings From Campania Leadless Registry
por: Russo, Vincenzo, et al.
Publicado: (2022)

The Effect of Sacubitril/Valsartan on Device Detected Arrhythmias and Electrical Parameters among Dilated Cardiomyopathy Patients with Reduced Ejection Fraction and Implantable Cardioverter Defibrillator
por: Russo, Vincenzo, et al.
Publicado: (2020)

Remote monitoring of implantable loop recorders reduces time to diagnosis in patients with unexplained syncope: a multicenter propensity score-matched study
por: Russo, Vincenzo, et al.
Publicado: (2023)

COVID-19 and Heart: From Clinical Features to Pharmacological Implications
por: Russo, Vincenzo, et al.
Publicado: (2020)

Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation
por: Carbone, Andreina, et al.
Publicado: (2022)

Device-Related Complications and Inappropriate Therapies Among Subcutaneous vs. Transvenous Implantable Defibrillator Recipients: Insight Monaldi Rhythm Registry
por: Russo, Vincenzo, et al.
Publicado: (2022)

A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation
por: Patti, Giuseppe, et al.
Publicado: (2022)

Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study
por: NIGRO, GERARDO, et al.
Publicado: (2012)

Arrhythmias and Sudden Cardiac Death in Beta-Thalassemia Major Patients: Noninvasive Diagnostic Tools and Early Markers
por: Russo, Vincenzo, et al.
Publicado: (2019)

Ventricular fibrillation induced by coagulating mode bipolar electrocautery during pacemaker implantation in Myotonic Dystrophy type 1 patient
por: RUSSO, VINCENZO, et al.
Publicado: (2014)

Cardiac resynchronization improves heart failure in one patient with Myotonic Dystrophy type 1. A case report
por: RUSSO, VINCENZO, et al.
Publicado: (2012)

Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patients
por: Russo, Vincenzo, et al.
Publicado: (2012)

Inappropriate shocks due to air entrapment in patients with subcutaneous implantable cardioverter‐defibrillator: A meta‐summary of case reports
por: Iavarone, Michele, et al.
Publicado: (2022)

Atrial Fibrillation and Beta Thalassemia Major: The Predictive Role of the 12-lead Electrocardiogram Analysis
por: Russo, Vincenzo, et al.
Publicado: (2014)

Intermuscular technique for implantation of the subcutaneous implantable defibrillator: a propensity-matched case–control study
por: Botto, Giovanni Luca, et al.
Publicado: (2023)

Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
por: Hohnloser, Stefan H, et al.
Publicado: (2019)

Cardioinhibitory syncope with asystole during nitroglycerin potentiated head up tilt test: prevalence and clinical predictors
por: Russo, Vincenzo, et al.
Publicado: (2022)

Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
Publicado: (2019)

Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial
por: Kozieł, Monika, et al.
Publicado: (2020)

Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up
por: RUSSO, VINCENZO, et al.
Publicado: (2013)

Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial
por: Hohnloser, Stefan H, et al.
Publicado: (2020)

Drug management of atrial fibrillation in light of guidelines and current evidence: an Italian Survey on behalf of Italian Association of Arrhythmology and Cardiac Pacing
por: Diemberger, Igor, et al.
Publicado: (2023)

Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients
por: Russo, Vincenzo, et al.
Publicado: (2020)

Adenosine-induced sinus tachycardia in a patient with Myotonic Dystrophy type 1
por: Russo, Vincenzo, et al.
Publicado: (2014)

Voltage-directed cavo-tricuspid isthmus ablation using a novel ablation catheter mapping technology in a myotonic dystrophy type I patient
por: Russo, Vincenzo, et al.
Publicado: (2016)

Early evaluation of atrial high rate episodes using remote monitoring in pacemaker patients: Results from the RAPID study
por: Russo, Vincenzo, et al.
Publicado: (2022)

Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study
por: Russo, Vincenzo, et al.
Publicado: (2022)

Factors Associated With Edoxaban Concentration Among Patients With Atrial Fibrillation
por: Lin, Shin-Yi, et al.
Publicado: (2021)

Correction to: Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study
por: Russo, Vincenzo, et al.
Publicado: (2023)

Case report: Lamin A/C gene mutation in patient with drug-induced type 1 Brugada syndrome at high arrhythmic risk
por: Russo, Vincenzo, et al.
Publicado: (2023)

Cardiac implantable electronic devices replacements in patients followed by remote monitoring during COVID-19 lockdown
por: Russo, Vincenzo, et al.
Publicado: (2021)

Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population
por: Russo, Vincenzo, et al.
Publicado: (2016)

Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?
por: Camporese, Giuseppe, et al.
Publicado: (2020)

Edoxaban Monotherapy in Nonvalvular Atrial Fibrillation Patients with Coronary Artery Disease
por: Fukamachi, Daisuke, et al.
Publicado: (2022)

Far field R-wave sensing in Myotonic Dystrophy type 1: right atrial appendage versus Bachmann's bundle region lead placement
por: Russo, Vincenzo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f9sgvmocced6gvv610mpnirmt4